SciHub
文献互助
期刊查询
一搜即达
科研导航
交流社区
登录
注册
发布
文献
求助
首页
我的求助
捐赠本站
豆豆
Lv3
260 积分
2023-05-23 加入
最近求助
最近应助
互助留言
Response Evaluation Criteria in Cancer of the Liver version 5 (RECICL 2019 revised version)
10天前
已完结
Clinical benefit of continuing pembrolizumab treatment beyond progression in patients with metastatic urothelial carcinoma
1个月前
已完结
Comparison of the Immunotherapy Response Evaluation Criteria in Solid Tumours (iRECIST) with RECIST for capturing treatment response of patients with metastatic urothelial carcinoma treated with pembrolizumab
1个月前
已完结
Atezolizumab plus bevacizumab versus active surveillance in patients with resected or ablated high-risk hepatocellular carcinoma (IMbrave050): a randomised, open-label, multicentre, phase 3 trial
5个月前
已完结
Microwave ablation versus laparoscopic resection as first‐line therapy for solitary 3–5‐cm HCC
5个月前
已完结
No-touch multibipolar radiofrequency ablation vs. surgical resection for solitary hepatocellular carcinoma ranging from 2 to 5 cm
5个月前
已完结
Impact of HBsAg seroclearance on late recurrence of hepatitis B virus-related hepatocellular carcinoma after surgical resection
5个月前
已完结
Positive serum hepatitis B e antigen is associated with higher risk of early recurrence and poorer survival in patients after curative resection of hepatitis B-related hepatocellular carcinoma
5个月前
已完结
Adjuvant transarterial chemo‐ embolization for HBV‐related hepatocellular carcinoma after resection: a randomized controlled study
5个月前
已完结
Association of Adjuvant Radiation Therapy With Long-Term Overall and Recurrence-Free Survival After Hepatectomy for Hepatocellular Carcinoma: A Multicenter Propensity-Matched Study
5个月前
已完结
没有进行任何应助
感谢,点赞,速度真快,帮大忙了,么么哒
10天前
感谢,点赞,速度真快,帮大忙了,么么哒
1个月前
感谢,帮大忙了,点赞,速度真快
5个月前
感谢,点赞,帮大忙了
5个月前
感谢,点赞,速度真快
5个月前
感谢,速度真快,么么哒
5个月前
感谢,速度真快,帮大忙了
5个月前
感谢,点赞,速度真快,,么么哒
5个月前
感谢,点赞,速度真快
5个月前
感谢,速度真快,帮大忙了,么么哒
5个月前
最近帖子
最近评论
没有发布任何帖子
没有发布任何评论